Conservative management in hypertriglyceridemia-associated pancreatitis

© 2019 The Association for the Publication of the Journal of Internal Medicine..

BACKGROUND: Severe hypertriglyceridemia (serum triglyceride >10 mmol L-1 ) is implicated in ~9% of acute pancreatitis cases. Certain guidelines list severe hypertriglyceridemia as an indication for plasmapheresis.

OBJECTIVE: We assembled the natural trajectory of triglyceride levels in patients with acute pancreatitis due to severe hypertriglyceridemia who were managed conservatively without plasmapheresis to evaluate the effectiveness of this approach.

METHODS: A retrospective chart review was performed on 22 hospital admissions for acute pancreatitis episodes considered to be caused by severe hypertriglyceridemia. Patients were managed supportively, with cessation of oral intake (NPO) and intravenous hydration. Insulin infusion was used in 12 patients to manage concurrent hyperglycaemia.

RESULTS: Triglyceride levels for the group were evaluated using a mixed-effects model. The average triglyceride level fell from 45.4 mmol L-1 on presentation to 13.3 mmol L-1 within 48 h, corresponding to a mean 69.8% decrease. Regression analysis showed a triglyceride half-life of 30.6 h. Findings were similar for NPO-only and insulin infusion subgroups.

CONCLUSION: Patients with severe hypertriglyceridemia and acute pancreatitis can be conservatively managed safely and effectively without plasmapheresis.

Errataetall:

CommentIn: J Intern Med. 2019 Dec;286(6):723-725. - PMID 31454465

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:286

Enthalten in:

Journal of internal medicine - 286(2019), 6 vom: 15. Dez., Seite 644-650

Sprache:

Englisch

Beteiligte Personen:

Berberich, A J [VerfasserIn]
Ziada, A [VerfasserIn]
Zou, G Y [VerfasserIn]
Hegele, R A [VerfasserIn]

Links:

Volltext

Themen:

Hypertriglyceridemia
Insulin
Journal Article
Observational Study
Pancreatitis
Plasma exchange
Plasmapheresis
Research Support, Non-U.S. Gov't
Triglycerides

Anmerkungen:

Date Completed 25.05.2020

Date Revised 25.05.2020

published: Print-Electronic

CommentIn: J Intern Med. 2019 Dec;286(6):723-725. - PMID 31454465

Citation Status MEDLINE

doi:

10.1111/joim.12925

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM296965820